Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation

Journal of Nuclear Medicine

Volumn 37, Issue 4 SUPPL., 1996, Pages

  Foulon, Catherine F ^a   Adelstein, S James ^a   Kassis, Amin I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Shields Warren Radiation Laboratory   (United States)

Author keywords

Iododemercuration; Iododeoxyuridine; Iododestannylation

Indexed keywords

DIAGNOSTIC AGENT; IDOXURIDINE; RADIOACTIVE IODINE;

ANALYTICAL EQUIPMENT; ARTICLE; COMPARATIVE STUDY; HUMAN; ISOTOPE LABELING; METHODOLOGY; TIME;

HUMANS; IDOXURIDINE; IODINE RADIOISOTOPES; ISOTOPE LABELING; REAGENT KITS, DIAGNOSTIC; TIME FACTORS;

EID: 0030119622     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol 1975;28:225-241.
2. 3HTdR. Radiat Res 1976;67:332-343.
3. 125I in mammalian cells. Radiat Res 1987;111:305-318.
4. 125I]iodo-2′-deoxyuridine. Radiat Res 1989;118:532-544.
5. 125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature 1977;265:620-621.
6. 123I]Iodo-2′-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys 1991;21:1541-1551.
7. 125I]Iodo-2′-deoxyuridine in the radiotherapy of solid brain tumors in rats [Abstract]. J Nucl Med 1993;34(suppl):241P.
8. 125I)Iodo-2′-deoxyuridine for cancer diagnosis and therapy. J Nucl Med Allied Sci 1990;34:299-303.
9. 125I]iodo-2′-deoxyuridine in cancer. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical aspects of Auger processes, American Association of Physicists in Medicine Symposium Series no. 8. Woodbury, NY: American Institute of Physics; 1992:372-395.
10. 125I]iodo-2′-deoxyuridine following intratumoral injection in patients with colorectal cancer. J Nucl Med 1993;34:1175-1183.
11. 125IUdR in a rat model of meningeal carcinomatosis [Abstract]. Proc Am Assoc Cancer Res 1994;35:414.
12. 125I]iodo-2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990;50:5199-5203.
13. 123I]iodo-2′-deoxyuridine into the hepatic artery of patients with liver metastases from colorectal cancer [Abstract]. J Nucl Med 1994;35(suppl):144P.
14. 125I]IUdR therapy [Abstract]. J Nucl Med 1994;35(suppl):144P.
15. Wilbur DS. Radiohalogenation of proteins: an overview of radionuclides, labeling methods and reagents for conjugate labeling. Bioconjug Chem 1992;3:433-470.
16. 123/125/127I]iodo-2′-deoxyuridine. Appl Radiat Isot 1988;39:335-341.
17. Foulon CF, Zhang YZ, Adelstein SJ, Kassis AI. Instantaneous preparation of radiolabeled 5-iodo-2′-deoxyuridine. Appl Radiat Isot 1995;46:1039-1046.
18. Baranowska-Kortylewicz J, Helseth LD, Lai J, Schneiderman MU, Schneiderman GS, Dalrymple GV. Radiolabeling kit/generator for 5-radiohalogenated undines. J Lab Compd Radiopharm 1994;34:513-521.
19. U.S. Public Health Service, Agency for Toxic Substances and Disease Registry. Toxicological profile for mercury. Atlanta, GA: Department of Health and Human Services, Public Health Service Centers for Disease Control; 1990:11.
20. Goyer RA. Toxic effects of metals. In: Klaassen CD, Amdur MO, Doull J, eds. Casarett and Doull's toxicology: the basic science of poisons, 3rd ed. New York: Macmillan; 1986:582-635.
21. World Health Organization, International Programme on Chemical Safety. Environmental health criteria 116: tributyltin compounds. Geneva: World Health Organization; 1990:193.